» Articles » PMID: 29344321

Fixed Drug Eruption to Supplement Containing Ginkgo Biloba and Vinpocetine: A Case Report and Review of Related Cutaneous Side Effects

Overview
Date 2018 Jan 19
PMID 29344321
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Fixed drug eruption is a cutaneous reaction to a systemic agent that typically presents as an annular or oval erythematous patch or blister and subsequently resolves with postinflammatory hyperpigmentation at the site. leaf extract and vinpocetine are nutritional supplements used to enhance memory in patients with dementia and age-related memory impairment conditions such as Alzheimer's disease. To describe a fixed drug eruption in a man who repeatedly developed pruritus and macular erythema on his distal penile shaft after ingesting a natural product containing and vinpocetine. The medical literature was retrospectively reviewed using PubMed, searching specifically for the terms and Patient reports and previous reviews of the subject were critically assessed, and the salient features of cutaneous adverse effects in patients receiving either or vinpocetine are presented. Cutaneous adverse effects from and vinpocetine are infrequent. fruit can result in contact dermatitis (following topical exposure) and mucosal symptoms of the mouth and anus (following oral exposure); in addition, an erythematous maculopapular generalized eruption or possibly Steven-Johnson syndrome can occur after oral ingestion of the leaf extract. Facial erythema has been associated with vinpocetine ingestion. Pruritus and an annular erythema localized to the distal penile shaft developed after initial and repeat ingestion of a biloba/vinpocetine product. and vinpocetine should be added to the agents that can potentially cause a fixed drug eruption.

Citing Articles

Paintball Purpura: The Ball Sports-induced Targetoid Erythema (SITE) Sign Revisited.

Hassan S, Cohen P Cureus. 2020; 12(5):e8056.

PMID: 32537274 PMC: 7286584. DOI: 10.7759/cureus.8056.

References
1.
SOWERS W, Weary P, COLLINS O, CAWLEY E . GINKGO-TREE DERMATITIS. Arch Dermatol. 1965; 91:452-6. DOI: 10.1001/archderm.1965.01600110038009. View

2.
Mizukawa Y, Shiohara T . Fixed drug eruption: a prototypic disorder mediated by effector memory T cells. Curr Allergy Asthma Rep. 2008; 9(1):71-7. DOI: 10.1007/s11882-009-0011-8. View

3.
Mahadevan S, Park Y . Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses. J Food Sci. 2008; 73(1):R14-9. DOI: 10.1111/j.1750-3841.2007.00597.x. View

4.
Sasseville D . Clinical patterns of phytodermatitis. Dermatol Clin. 2009; 27(3):299-308, vi. DOI: 10.1016/j.det.2009.05.010. View

5.
Szatmari S, Whitehouse P . Vinpocetine for cognitive impairment and dementia. Cochrane Database Syst Rev. 2003; (1):CD003119. PMC: 8406981. DOI: 10.1002/14651858.CD003119. View